Keeping Current

Are you aware of the rapid progress for patients with epidermal growth factor receptor (EGFR) exon 20 insertion-mutated non-small cell lung cancer (NSCLC) and strategies for tackling osimertinib resistance? Credit available for this activity expires: [07/11/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976634?src=mkm_podcast_addon_976634

Can you recognize respiratory syncytial virus (RSV) in older adults? Credit available for this activity expires: 6/30/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976248?src=mkm_podcast_addon_976248

Did you know that up to 70% of patients with Wilson disease (WD) experience neuropsychological symptoms at some point in the disease course? Credit available for this activity expires: 6/30/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976141?src=mkm_podcast_addon_976141

Is it true that only 5% of people with epilepsy will become seizure-free after 2 failed anti-seizure medicines (ASMs)? Find out why this isn't really the case, and why we should aim higher. Credit available for this activity expires: 6/30/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975359?src=mkm_podcast_addon_975359

Did you know that the severity of generalized pustular psoriasis (GPP) can be so great that up to 30% of the body surface area can be involved in up to one-third of patients?  Credit available for this activity expires: 6/29/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976238?src=mkm_podcast_series_976238

How familiar are you with the role of complement pathways in the pathophysiology and management of complement-mediated kidney diseases? Credit available for this activity expires: 6/28/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976176?src=mkm_podcast_addon_976176

Did you know that more than 50% of physicians experience burnout and that burnout can lead to a loss of compassion? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976001?src=mkm_podcast_addon_976001

Are you up-to-date regarding benefits of novel anti-obesity drugs in people with obesity? Join Drs Sharma and Macklin to improve your knowledge. Credit available for this activity expires: 6/27/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976164?src=mkm_podcast_addon_976164

Did you know that we could be undertreating patients with psoriasis? Credit available for this activity expires: 6/24/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976067?src=mkm_podcast_addon_976067

International expert faculty discuss how sodium-glucose cotransporter-2 (SGLT2) inhibitors have changed the management of patients with heart failure (HF). Credit available for this activity expires: [06/24/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976002?src=mkm_podcast_addon_976002

Can anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help. Credit available for this activity expires: 6/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535

With incidence of food-induced anaphylaxis on the increase, are you up to date on how best to diagnose and manage patients with food allergies? Credit available for this activity expires: 6/21/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975719?src=mkm_podcast_addon_975719

Do you know the best imaging modalities to diagnose advanced age-related macular degeneration (AMD) and track its progress? Learn how to assess patients and how to discuss with them what the future may hold. Credit available for this activity expires: 6/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975758?src=mkm_podcast_addon_975758

Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 6/20/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726

Patients with extensive-stage small cell lung cancer (ES-SCLC) have a 10-month survival of 10 months following standard frontline chemotherapy. Join the experts in discussing immune checkpoint inhibitors (ICIs) in patients with SCLC. Credit available for this activity expires: 6/15/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975532?src=mkm_podcast_addon_975532

Do you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)? Credit available for this activity expires: 6/14/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383

What do the latest guidelines say about HF management? Drs Butler, Bozkurt, and McDonagh discuss. Credit available for this activity expires: 6/13/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975310?src=mkm_podcast_addon_975310

Do you know how and when to screen for depression in people with epilepsy, and when to manage depression and when to refer? Credit available for this activity expires: 6/10/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975275?src=mkm_podcast_addon_975275

Did you know that estrogen receptor-positive breast cancer often develops treatment resistance to endocrine therapy? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974726?src=mkm_podcast_addon_974726

Did you know that there is a paradigm shift in the definition of human epidermal growth factor receptor 2 (HER2) status in breast cancer? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974715?src=mkm_podcast_addon_974715